BC Innovations | Jan 31, 2017
Distillery Therapeutics

Ophthalmic disease

INDICATION: Choroidal neovascularization (CNV); retinal detachment In vitro and mouse studies suggest the COL4A5 -mimetic peptide AXT107 could help treat CNV and retinal detachment. In vitro , AXT107 bound integrins α v β 3 and α...
Items per page:
1 - 1 of 1